Pharma Journalist -

Ascendis Pharma A/S announced that the U.S. Food & Drug Administration (FDA) has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of adults with growth hormone…
Read More...

Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending…
Read More...

Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending an expanded label for Alhemo…
Read More...

Pfizer Inc. and BioNTech SE announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending…
Read More...

Pfizer Inc. has announced the completion of a global (excluding China) licensing agreement with Chinese biopharmaceutical company 3SBio Inc., securing exclusive rights to develop,…
Read More...

GSK plc has announced that the European Union has approved its drug Blenrep (belantamab mafodotin) in combination therapies for the treatment of adults with relapsed or refractory…
Read More...

Solid Biosciences Inc., a clinical-stage company focused on genetic medicines for neuromuscular and cardiac diseases, announced it has received Fast Track designation from the U.S. Food…
Read More...

Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission has approved a new indication for DARZALEX (daratumumab) subcutaneous (SC)…
Read More...

A new potential treatment for generalised myasthenia gravis (gMG), a rare and debilitating autoimmune neuromuscular disease, has shown promising results in a large international…
Read More...

Biotech company Kling Bio has announced a new collaboration and license option agreement with global pharmaceutical giant Sanofi aimed at accelerating the discovery of neutralizing…
Read More...